EXEL beats on Q2 earnings but misses revenues as lower collaboration income offsets strong Cabometyx sales growth.

Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...

Amazing opportunity available for a Data Analyst within the renewable energy industry, based in Bellville. The Analyst is expected to use existing tools and models for this reporting, as well as ...

Analysts fell to the sidelines weighing in on Medtronic (MDT – Research Report) and Exelixis (EXEL – Research Report) with neutral ratings, indicating that the experts are nei ...

"The effort to bring SysML v2 is the cumulative work of many OMG members over the last seven years. The result is a ...